Fundamental Analysis of LUMIRADX LTD(NASDAQ:LMDX) stock

Fundamental Rating

Overall LMDX gets a fundamental rating of 1 out of 10. We evaluated LMDX against 187 industry peers in the Health Care Equipment & Supplies industry. LMDX may be in some trouble as it scores bad on both profitability and health. LMDX is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

LMDX had negative earnings in the past year.

LMDX had a negative operating cash flow in the past year.

In the past 5 years LMDX always reported negative net income.

LMDX had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -99.18%, LMDX is doing worse than 82.91% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-99.18%
ROE	N/A
ROIC	N/A

ROA(3y)-54.66%

ROA(5y)-52.33%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

LMDX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

LMDX does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, LMDX has less shares outstanding

LMDX has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -6.66, we must say that LMDX is in the distress zone and has some risk of bankruptcy.

LMDX has a worse Altman-Z score (-6.66) than 72.86% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-6.66

ROIC/WACCN/A

WACC4.03%

2.3 Liquidity

LMDX has a Current Ratio of 1.97. This is a normal value and indicates that LMDX is financially healthy and should not expect problems in meeting its short term obligations.

LMDX's Current ratio of 1.97 is on the low side compared to the rest of the industry. LMDX is outperformed by 74.37% of its industry peers.

A Quick Ratio of 1.01 indicates that LMDX should not have too much problems paying its short term obligations.

The Quick ratio of LMDX (1.01) is worse than 82.41% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.97
Quick Ratio	1.01

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 1.80% over the past year.

Looking at the last year, LMDX shows a very negative growth in Revenue. The Revenue has decreased by -68.26% in the last year.

LMDX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 122.52% yearly.

EPS 1Y (TTM)1.8%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%72.41%

Revenue 1Y (TTM)-68.26%

Revenue growth 3Y122.52%

Revenue growth 5YN/A

Sales Q2Q%-53.02%

3.2 Future

Based on estimates for the next years, LMDX will show a very strong growth in Earnings Per Share. The EPS will grow by 22.53% on average per year.

Based on estimates for the next years, LMDX will show a decrease in Revenue. The Revenue will decrease by -3.56% on average per year.

EPS Next Y70.33%

EPS Next 2Y33.38%

EPS Next 3Y22.53%

EPS Next 5YN/A

Revenue Next Year-64.72%

Revenue Next 2Y-27.23%

Revenue Next 3Y-9.52%

Revenue Next 5Y-3.56%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

LMDX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LMDX. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as LMDX's earnings are expected to grow with 22.53% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y33.38%

EPS Next 3Y22.53%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for LMDX!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

LUMIRADX LTD

NASDAQ:LMDX (1/8/2024, 8:17:43 PM)

After market: 0.0136 0 (-15%)

0.016

-0.02 (-53.49%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap2.63M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-99.18%
ROE	N/A
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.37

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	1.97
Quick Ratio	1.01
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)1.8%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y70.33%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-68.26%

Revenue growth 3Y122.52%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

LUMIRADX LTD (LMDX)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens